Unknown

Dataset Information

Allogeneic and autologous serum eye drops: a pilot double-blind randomized crossover trial.


ABSTRACT:

Purpose

Serum eye drops (SEDs) are used to treat a variety of ocular surface defects. Serum eye drops (SEDs) are normally produced from the patient's blood. However, not all patients can donate sufficient or suitable blood, and logistics can be challenging. Allogeneic blood from voluntary blood donors does not have these disadvantages. Our aim was to evaluate whether autologous and allogeneic SEDs have comparable efficacy and tolerability.

Methods

In a prospective, double-blind crossover trial, patients with severe dry eyes were randomized to first receive autologous SEDs for one month, followed by one-month washout, before receiving allogeneic SEDs for 1 month; or receive the SED preparations in reverse order. The Ocular Surface Disease Index (OSDI) was the primary endpoint

SUBMITTER: van der Meer PF 

PROVIDER: S-EPMC9544559 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature